These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 18325660)

  • 41. Glial precursor cell transplantation therapy for neurotrauma and multiple sclerosis.
    Kulbatski I; Mothe AJ; Parr AM; Kim H; Kang CE; Bozkurt G; Tator CH
    Prog Histochem Cytochem; 2008; 43(3):123-76. PubMed ID: 18706353
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases.
    Schwartz M; Kipnis J
    J Neurol Sci; 2005 Jun; 233(1-2):163-6. PubMed ID: 15949502
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stem cell and progenitor cell transplantation in multiple sclerosis: the discrepancy between neurobiological attraction and clinical feasibility.
    Lassmann H
    J Neurol Sci; 2005 Jun; 233(1-2):83-6. PubMed ID: 15949497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regeneration and repair in multiple sclerosis: the view of experimental pathology.
    Blakemore WF
    J Neurol Sci; 2008 Feb; 265(1-2):1-4. PubMed ID: 17459413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood-derived stem cells.
    Sanberg PR; Eve DJ; Willing AE; Garbuzova-Davis S; Tan J; Sanberg CD; Allickson JG; Cruz LE; Borlongan CV
    Cell Transplant; 2011; 20(1):85-94. PubMed ID: 20887684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New directions in MS therapeutics: vehicles of hope.
    Fox RJ; Ransohoff RM
    Trends Immunol; 2004 Dec; 25(12):632-6. PubMed ID: 15530830
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Using stem cells in multiple sclerosis therapies.
    Muraro PA; Cassiani-Ingoni R; Martin R
    Cytotherapy; 2004; 6(6):615-20. PubMed ID: 15764028
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autologous and allogeneic hematopoietic stem cell transplantation for Multiple Sclerosis: perspective on mechanisms of action.
    Van Wijmeersch B; Sprangers B; Dubois B; Waer M; Billiau AD
    J Neuroimmunol; 2008 Jul; 197(2):89-98. PubMed ID: 18541311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The complex etiology of multiple sclerosis.
    Winquist RJ; Kwong A; Ramachandran R; Jain J
    Biochem Pharmacol; 2007 Nov; 74(9):1321-9. PubMed ID: 17537409
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL; Wiendl H
    Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Linkage between immunomodulation, neuroprotection and neurogenesis.
    Aharoni R; Arnon R
    Drug News Perspect; 2009; 22(6):301-12. PubMed ID: 19771319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
    Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adult stem cell transplantation in autoimmune disease.
    Tyndall A; Gratwohl A
    Curr Opin Hematol; 2009 Jul; 16(4):285-91. PubMed ID: 19465851
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pilot study of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells in amyotrophic lateral sclerosis (ALS).
    Cashman N; Tan LY; Krieger C; Mädler B; Mackay A; Mackenzie I; Benny B; Nantel S; Fabros M; Shinobu L; Yousefi M; Eisen A
    Muscle Nerve; 2008 May; 37(5):620-5. PubMed ID: 18335482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Toward the development of rational therapies in multiple sclerosis: what is on the horizon?
    Hemmer B; Hartung HP
    Ann Neurol; 2007 Oct; 62(4):314-26. PubMed ID: 17969020
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic potentials of stem cells in cardiac diseases.
    Strauer BE; Schannwell CM; Brehm M
    Minerva Cardioangiol; 2009 Apr; 57(2):249-67. PubMed ID: 19274033
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases.
    Sadan O; Shemesh N; Cohen Y; Melamed E; Offen D
    Isr Med Assoc J; 2009 Apr; 11(4):201-4. PubMed ID: 19603590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Future research directions in multiple sclerosis therapies.
    Greenberg BM; Calabresi PA
    Semin Neurol; 2008 Feb; 28(1):121-7. PubMed ID: 18256992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antioxidant therapy in multiple sclerosis.
    Mirshafiey A; Mohsenzadegan M
    Immunopharmacol Immunotoxicol; 2009; 31(1):13-29. PubMed ID: 18763202
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Vogt J; Paul F; Aktas O; Müller-Wielsch K; Dörr J; Dörr S; Bharathi BS; Glumm R; Schmitz C; Steinbusch H; Raine CS; Tsokos M; Nitsch R; Zipp F
    Ann Neurol; 2009 Sep; 66(3):310-22. PubMed ID: 19798635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.